Surgical Frontiers | Surgical Frontiers Announces Closing of $7 Million Fund
5739
post-template-default,single,single-post,postid-5739,single-format-standard,mkd-core-1.0.3,ajax_fade,page_not_loaded,, vertical_menu_with_scroll,smooth_scroll,side_menu_slide_from_right,fade_push_text_right,hide_inital_sticky,wpb-js-composer js-comp-ver-4.11.1,vc_responsive

Surgical Frontiers Announces Closing of $7 Million Fund

LOGAN, Utah–(BUSINESS WIRE)–Surgical Frontiers announces that it has recently closed on a $7 million fund to invest in its business incubator for surgical technology start-up companies focused primarily on musculoskeletal markets.

The fund will be held by Surgical Frontiers Series I, LLC and invested in portfolio companies incubated by the management and product development company, Surgical Frontiers, LLC. Initial funding commitments have been made to the first three portfolio companies addressing the following segments of the orthopedic medical device market: foot and ankle, sports medicine and trauma.

“By identifying unmet clinical needs and than applying our capital efficient model for business incubation, we plan to use this fund to develop highly differentiated surgical technologies that have the potential to improve patient outcomes,” stated Wade Fallin, CEO of Surgical Frontiers. “In addition to our current focus on these first three portfolio companies, our scalable business model allows us to pursue additional opportunities to collaborate with surgeons, industry and universities to fund, launch and operate development stage companies in the medical technology market.”

About Surgical Frontiers

Surgical Frontiers funds, launches and operates start-up companies to develop advanced surgical technologies that are ready for clinical use. Focused primarily on musculoskeletal injuries and pathologies, the company collaborates with surgeons, industry, universities and investors to bring advanced surgical technologies to the market that improve healthcare.

“In addition to our current focus on these first three portfolio companies, our scalable business model allows us to pursue additional opportunities to collaborate with surgeons, industry and universities to fund, launch and operate development stage companies in the medical technology market.”

No Comments

Post a Comment